Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Vince Biemans, Frank Hoentjen, Marieke Pierik
Abstract
Contains fulltext : 220029.pdf (Publisher’s version ) (Open Access)
Topics & Concepts
VedolizumabMedicineUlcerative colitisAdalimumabInternal medicineDermatologyGastroenterologyTumor necrosis factor alphaDiseaseInflammatory Bowel DiseaseMicroscopic ColitisCeliac Disease Research and Management